17. Baiji Xue<sup>#</sup>, Yuelan Zhang<sup>#</sup>, Man Xu<sup>#</sup>, Chuqiao Wang, Jinxiang Huang, Haoxiang Zhang, Shuhui Meng, Maobin Xie*, Ailin Tao*, Xuefeng Li*. Curcumin-silk fibroin nanoparticles for enhanced anticandida albicans activity in vitro and in vivo. Journal of Biomedical Nanotechnology, 2019, 15, 769-778.-Maobin Xie Research Group

Home

About Us: About Us Contact

Research: Research Topics Volumetric Bioprinting Bioink Drug Delivery

Publications: Publications Cover Gallery

Team: Principal Investigator Members Alumni

News: News in group Academic Lecture Group Activities

Join Us

Publications

Publications: 17. Baiji Xue^#, Yuelan Zhang^#, Man Xu^#, Chuqiao Wang, Jinxiang Huang, Haoxiang Zhang, Shuhui Meng, Maobin Xie*, Ailin Tao*, Xuefeng Li*. Curcumin-silk fibroin nanoparticles for enhanced anticandida albicans activity in vitro and in vivo. Journal of Biomedical Nanotechnology, 2019, 15, 769-778.

2019-04-01

Previous：16. Maobin Xie*, Man Xu, Xiaoming Chen, Yi Li*. Recent progress of supercritical carbon dioxide in producing natural nanomaterials. Mini-Reviews in Medicinal Chemistry, 2019, 19, 465-476.Next：18. Xiaoying Guan, Bin Yang, Maobin Xie, Deependra Kumar Ban, Xinmin Zhao, Ratnesh Lal, Feng Zhang. MRI reporter gene MagA suppresses transferrin receptor and maps Fe²⁺ dependent lung cancer. Nanomedicine: Nanotechnology, Biology, and Medicine, 2019, 21, 102064.